Peptide Antibiotics Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Global Peptide Antibiotics Market

Uncover key drivers, emerging technologies, and competitive movements shaping the peptide antibiotics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Peptide Antibiotics Market And What Value Is Projected For 2029?

The peptide antibiotics market size has experienced significant expansion in recent years. It is projected to increase from $5.25 billion in 2024 to $5.77 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.8%. The growth observed in the past can be credited to the discovery and refinement of peptide antibiotics, the increasing prevalence of antibiotic resistance, a surge in the incidence of infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.

The peptide antibiotics market is anticipated to show significant growth in the upcoming years, projected to reach $8.29 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.5%. This expansion over the forecast period is attributed to an increased emphasis on developing novel antibiotics, the rising global prevalence of antibiotic-resistant infections, broader research and development in antimicrobial peptides, and supportive regulatory environments for new antibiotic approvals. Prominent trends expected during this period involve exploring natural sources for antimicrobial peptides, applying peptide antibiotics in animal health, concentrating on peptide engineering to enhance efficacy, developing combination peptide antibiotics, and integrating AI and machine learning in the discovery of peptide antibiotics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Factors Are Boosting The Peptide Antibiotics Market?

The growing incidence of diverse infectious diseases is projected to drive expansion within the peptide antibiotics market. These diseases are conditions resulting from detrimental microorganisms, including bacteria, fungi, parasites, and other agents. Key factors contributing to this surge in infectious illnesses include rapid urbanization, shifting climate patterns, and a heightened risk of new diseases emerging, all of which have escalated the need for peptide antibiotics. Peptide antibiotics function by physically disrupting cell membranes, thereby forming the basis of their antibacterial action. For example, data from May 2024, provided by the World Health Organization, a Switzerland-based intergovernmental body, indicated that dengue cases in the America region had already exceeded seven million by April 2024, significantly surpassing the 4.6 million cases documented throughout 2023. Consequently, the rising occurrence of infectious diseases is fueling the growth of the peptide antibiotics market.

What Are The Core Segmentation Criteria In The Peptide Antibiotics Market?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Which Emerging Trends Are Reshaping The Peptide Antibiotics Market Landscape?

Strategic collaborations are emerging as a significant trend in the peptide antibiotics market. Key players in this sector are engaging in partnerships to expand their market presence and leverage mutual resources. For example, in January 2022, Berkeley Lights, a US-based digital cell biology company, formed a partnership with Aanika Biosciences. Through this alliance, Aanika will utilize Berkeley Lights’ high-throughput, functional screening service to quickly discover and optimize functional antimicrobial peptides (AMPs) capable of eradicating dangerous bacteria, especially those causing foodborne disease outbreaks. Moreover, the Beacon Optofluidic Platform will be instrumental in identifying peptides harmful to bacteria, enabling the development of a new antibacterial tag. This tag will then be incorporated into their bacterial spore-based barcoding technology to enhance the security of the food supply chain. Aanika Biosciences is a US-based biotechnology company.

Which Players Are Shaping The Competitive Landscape Of The Peptide AntibioticsXX Market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

What Regional Trends Are Shaping Growth In The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

Browse Through More Reports Similar to the Global Peptide Antibiotics Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nutritional Feed Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Pharmacies And Drug Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model